Verily vs Caris Life Sciences: Jobs & Salary Guide
Company Focus ¶
- Verily (Alphabet/Google): Healthcare technology and data science platform focusing on precision health
- Caris: Molecular science company pioneering precision diagnostics and clinical AI
Caris Life Sciences is a private company, and Verily is an Alphabet subsidiary. Both companies are tech and data focused, meaning you’ll likely see more job opportunities for software and data science focused positions than other big pharma. However, Verily describe themselves as innovating at the “intersection of health and tech”1, and Caris frequently mentions their focus on Molecular Artificial Intelligence and claims to hold the world’s first fully validated AI-based treatment algorithm" for colorectal cancer called FOLFIRSTai2.
Role Distribution ¶
We classify jobs into broad categories to facilitate role company comparisons. You can learn more about how we classify and find and search by jobs on our pharma and biotech career paths page.
- Verily emphasizes software engineering and data science roles
- Caris has stronger focus on clinical operations and laboratory positions
- Both companies actively hire in scientific research
Historical Hiring Trends ¶
Job Posting Salary Ranges ¶
We don’t have quite enough data to do a fair salary range comparison.
Current Job Listings ¶
Browse current openings:
- Verily Life Sciences Jobs
- Caris Life Sciences Jobs
- See the most recent postings from across the industry
The data on our job comparison pages is updated at least once per day. If you find a mistake or want to suggest another comparison, please send us an email.
FOLFirstai is a tool to assess whether metastic colorectal cancer patients will benefit from first line treatments like FOLFOX+BV FOLFIRI+BV see https://www.carislifesciences.com/physicians/physician-tests/caris-folfirstai/ and the publication https://aacrjournals.org/clincancerres/article/27/4/1174/125088/Clinical-Validation-of-a-Machine-learning-derived ↩︎